TH99002A - Carbinaldi Riveviv, which has been replaced - Google Patents
Carbinaldi Riveviv, which has been replacedInfo
- Publication number
- TH99002A TH99002A TH701006102A TH0701006102A TH99002A TH 99002 A TH99002 A TH 99002A TH 701006102 A TH701006102 A TH 701006102A TH 0701006102 A TH0701006102 A TH 0701006102A TH 99002 A TH99002 A TH 99002A
- Authority
- TH
- Thailand
- Prior art keywords
- symptoms
- diabetes
- carbinaldirvativ
- salvate
- atheroma
- Prior art date
Links
- 208000024891 symptom Diseases 0.000 claims abstract 8
- 239000008280 blood Substances 0.000 claims abstract 4
- 210000004369 blood Anatomy 0.000 claims abstract 4
- 206010012601 diabetes mellitus Diseases 0.000 claims abstract 4
- 206010003210 Arteriosclerosis Diseases 0.000 claims abstract 2
- 201000001320 Atherosclerosis Diseases 0.000 claims abstract 2
- 208000037260 Atherosclerotic Plaque Diseases 0.000 claims abstract 2
- 102000004127 Cytokines Human genes 0.000 claims abstract 2
- 108090000695 Cytokines Proteins 0.000 claims abstract 2
- 206010012434 Dermatitis allergic Diseases 0.000 claims abstract 2
- 201000008937 atopic dermatitis Diseases 0.000 claims abstract 2
- 208000010668 atopic eczema Diseases 0.000 claims abstract 2
- 229940125388 beta agonist Drugs 0.000 claims abstract 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims abstract 2
- -1 cholesterol Lipid Chemical class 0.000 claims abstract 2
- 230000015271 coagulation Effects 0.000 claims abstract 2
- 238000005345 coagulation Methods 0.000 claims abstract 2
- 201000010099 disease Diseases 0.000 claims abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 208000027866 inflammatory disease Diseases 0.000 claims abstract 2
- 230000002757 inflammatory effect Effects 0.000 claims abstract 2
- 239000003223 protective agent Substances 0.000 claims abstract 2
- 150000003839 salts Chemical class 0.000 claims abstract 2
- 239000000126 substance Substances 0.000 claims abstract 2
- 229940079593 drug Drugs 0.000 claims 1
Abstract
DC60 (25/02/51) การประดิษฐ์นี้เป็นการนำเสนอ LXRเบตา อาโกนิสต์แบบใหม่ซึ่งเป็นประโยชน์เป็นสารป้องกัน และ/หรือรักษา อาการหลอดโลหิตแดงแข็งตัวประเภทอาการหลอดโลหิตแดงแข็งตัวแบบอะเทอโรมา กับอาการหลอดโลหิตแดงแข็งตัวอันเนื่องมาจากโรคเบาหวาน เป็นต้น อาการโลหิตมีไขมันมากเกินไป อาการโคเลสเทอรอลในเลือดสูง อาการเกี่ยวกับลิพิด โรคอักเสบซึ่งเป็นโรคที่เกิดจากไซโตไคน์อักเสบ โรคผิวหนังประเภทโรคผิวหนังเกิดภูมิแพ้ โรคเบาหวานหรืออัลไซเมอร์ คาร์บินอลดีริวาทิฟที่สามารถแสดงด้วยสูตรทั่วไปที่ (1) ต่อไปนี้หรือเกลือนั้นหรือซอลเวตของ สิ่งเหล่านั้น [เคมี 1] (สูตรเคมี) (I) สิทธิบัตรยา DC60 (25/02/51) This invention presents a new, useful new beta-agonist LXR as a protective agent. And / or maintain Atherosclerosis type Atheroma With symptoms of arterial coagulation due to diabetes, etc., blood symptoms have too much fat. Symptoms of high blood cholesterol Lipid symptoms Inflammatory disease, which is a disease caused by inflammatory cytokines Allergic dermatitis Diabetes or Alzheimer's Carbinaldirvativ can be represented by the general formula (1) or that salt or salvate of Those [chemistry 1] (chemical formula) (i) patent medicine
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH99002A true TH99002A (en) | 2009-11-06 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rodríguez-Calvo et al. | Molecular genetics of sudden cardiac death | |
| Liang et al. | Reactive oxygen species trigger NF-κB-mediated NLRP3 inflammasome activation induced by zinc oxide nanoparticles in A549 cells | |
| EP1726580A4 (en) | AMINOPHENYLPROPANSÄUREDERIVAT | |
| MA71363A (en) | 1-HYDROXY-4-(TRIFLUOROMETHYL)-1,3-DIHYDROBENZO[C][1,2]OXABOROLE-6-CARBOXYLIC ACID AND ITS USE IN THE SYNTHESIS OF GLUCOSE-SENSITIVE ALBUMIN-LINKING DERIVATIVES | |
| ECSP088414A (en) | DERIVATIVES OF BIFENYLLOXYACETIC ACID FOR THE TREATMENT OF A RESPIRATORY DISEASE | |
| CL2007002347A1 (en) | COMPOUNDS DERIVED FROM PHENYLL, PYRIDINE AND QUINOLINE; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND IN THE TREATMENT OF MELLITUS DIABETES, DISORDERS IN THE TOLERANCE OF GLUCOSE, OBESITY, CROHN'S DISEASE, SICK | |
| WO2006108582A3 (en) | Human marker genes and agents for diagnosis, treatment and prophylaxis of cardiovascular disorders and artherosclerosis | |
| EA201401231A1 (en) | PHARMACEUTICAL COMBINATIONS INTENDED FOR THE TREATMENT OF METABOLIC DISORDERS | |
| PE20121187A1 (en) | ARYLATED CANPHENES WITH ACTIVITY ON CB2 RECEPTORS AND PROCESSES FOR THEIR PREPARATION | |
| BR112014014869A2 (en) | sulfonylaminopyrrolidinone derivatives, their preparation and their therapeutic application | |
| TH99002A (en) | Carbinaldi Riveviv, which has been replaced | |
| WO2008070311A3 (en) | Gene expression profiling of parkinson's disease | |
| MX2009005753A (en) | Modulation of prostaglandin/cyclooxygenase metabolic pathways. | |
| BRPI1008415A2 (en) | use of cardiotrophin-1 for the treatment of metabolic diseases | |
| WO2008048691A3 (en) | Use of leptin for treating post-lipectomy ectopic fat deposition and other post-lipectomy associated disorders | |
| TH96115A (en) | Sulfonamide derivatives | |
| Yeon-Ho | Severe traumatic intraocular injuries related to blowout fractures | |
| EA201490618A1 (en) | SUBSTITUTED 2- (CHROMAN-6-ILOXI) THIAZOLES AND THEIR USE AS PHARMACEUTICAL FACILITIES | |
| TH1701003624A (en) | Bialryl derivative of GPR120 agonist form. | |
| Leo et al. | The delirious substance abuser | |
| CU23506B6 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING NITROVINYLFURANIC DERIVATIVES FOR THE TREATMENT OF LEISHMANIOSIS AND TRIPANOSOMOSIS | |
| Kowalewski et al. | Unknown: Scaly, circular papules in a healthy toddler | |
| Vuković et al. | Are we burnt out from our work?-signs of burnout in Medical Oncology residents | |
| Tsoi et al. | Abstracts from the 33rd Annual Scientific Meeting of the Canadian Geriatrics Society Toronto, April 2013 | |
| TH79571A (en) | Formate derivatives for treatment |